Literature DB >> 22096029

Control of glycolysis through regulation of PFK1: old friends and recent additions.

I Mor1, E C Cheung, K H Vousden.   

Abstract

Regulation of glucose metabolism is a crucial aspect of cell physiology in normal and disease conditions. Many regulatory events are involved in determining the metabolic fate of glucose and the pathways into which it is directed. The first reaction that commits glucose to the glycolytic pathway is catalyzed by the enzyme phosphofructokinase-1 (PFK-1) and is tightly regulated. One of the most potent activators of PFK-1 is fructose 2,6 bisphosphate (F2,6BP) and its cellular levels are correlated with glycolytic flux. F2,6BP is synthesized and degraded by a family of bifunctional enzymes-the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFB). The interplay among F2,6BP levels, the enzymes that generate and degrade it, and PFK-1 activity has important consequences for several different aspects of cell metabolism as well as for systemic metabolic conditions. TIGAR, a recently identified F2,6 bisphosphatase (F2,6BPase), could also contribute to this complexity and participate in shaping the metabolic profile of the cell.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22096029     DOI: 10.1101/sqb.2011.76.010868

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  99 in total

Review 1.  Fructose and Fructans: Opposite Effects on Health?

Authors:  Francesca Di Bartolomeo; Wim Van den Ende
Journal:  Plant Foods Hum Nutr       Date:  2015-09       Impact factor: 3.921

2.  Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function.

Authors:  Jorge Suarez; Federico Cividini; Brian T Scott; Kim Lehmann; Julieta Diaz-Juarez; Tanja Diemer; Anzhi Dai; Jorge A Suarez; Mohit Jain; Wolfgang H Dillmann
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

3.  Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.

Authors:  Brooke M Emerling; Jonathan B Hurov; George Poulogiannis; Kazumi S Tsukazawa; Rayman Choo-Wing; Gerburg M Wulf; Eric L Bell; Hye-Seok Shim; Katja A Lamia; Lucia E Rameh; Gary Bellinger; Atsuo T Sasaki; John M Asara; Xin Yuan; Andrea Bullock; Gina M Denicola; Jiaxi Song; Victoria Brown; Sabina Signoretti; Lewis C Cantley
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

4.  The fructose-2,6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC.

Authors:  Yan Tang; Hyokjoon Kwon; Brian A Neel; Michal Kasher-Meron; Jacob B Pessin; Eijiro Yamada; Jeffrey E Pessin
Journal:  J Biol Chem       Date:  2018-04-12       Impact factor: 5.157

5.  Glycolytic reliance promotes anabolism in photoreceptors.

Authors:  Yashodhan Chinchore; Tedi Begaj; David Wu; Eugene Drokhlyansky; Constance L Cepko
Journal:  Elife       Date:  2017-06-09       Impact factor: 8.140

Review 6.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Authors:  Parul Mehra; Yiru Guo; Yibing Nong; Pawel Lorkiewicz; Marjan Nasr; Qianhong Li; Senthilkumar Muthusamy; James A Bradley; Aruni Bhatnagar; Marcin Wysoczynski; Roberto Bolli; Bradford G Hill
Journal:  Basic Res Cardiol       Date:  2018-10-23       Impact factor: 17.165

8.  Cardiac Ryanodine Receptor (Ryr2)-mediated Calcium Signals Specifically Promote Glucose Oxidation via Pyruvate Dehydrogenase.

Authors:  Michael J Bround; Rich Wambolt; Haoning Cen; Parisa Asghari; Razvan F Albu; Jun Han; Donald McAfee; Marc Pourrier; Nichollas E Scott; Lubos Bohunek; Jerzy E Kulpa; S R Wayne Chen; David Fedida; Roger W Brownsey; Christoph H Borchers; Leonard J Foster; Thibault Mayor; Edwin D W Moore; Michael F Allard; James D Johnson
Journal:  J Biol Chem       Date:  2016-09-12       Impact factor: 5.157

Review 9.  PTEN in cancer, metabolism, and aging.

Authors:  Ana Ortega-Molina; Manuel Serrano
Journal:  Trends Endocrinol Metab       Date:  2012-12-12       Impact factor: 12.015

Review 10.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.